Critical influence of natural regulatory CD25+ T cells on the fate of allografts in the absence of immunosuppression

Transplantation

Volumn 79, Issue 6, 2005, Pages 648-654

  Benghiat, Fleur Samantha ^a   Graca, Luis ^b,c   Braun, Michel Y ^a   Detienne, Sophie ^a   Moore, Fabrice ^a   Buonocore, Sofia ^a   Flamand, Véronique ^a   Waldmann, Herman ^b   Goldman, Michel ^a   Le Moine, Alain ^a,d  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^d Institute for Medical Immunology   (Belgium)

Author keywords

Allograft; Regulatory T cell; Tolerance

Indexed keywords

CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 5; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY PC61; UNCLASSIFIED DRUG;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; EOSINOPHIL; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HLA MATCHING; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE DEPLETION; MALE; MIXED LYMPHOCYTE CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN ALLOGRAFT; T LYMPHOCYTE; TH1 CELL; TH2 CELL; TRANSGENIC MOUSE;

ANIMALS; CYTOKINES; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOSUPPRESSION; LYMPHOCYTE CULTURE TEST, MIXED; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RATS; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, INTERLEUKIN-2; SKIN TRANSPLANTATION; T-LYMPHOCYTES; TH1 CELLS; TH2 CELLS; TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 20144386868     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000155179.61445.78     Document Type: Article

References (31)

1. Asakura H, Ku G, Kataoka M, et al. Regulatory cells develop after the spontaneous acceptance of rat liver allografts. Surgery 2004; 136: 532.
2. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003; 3: 199.
3. Graca L, Le Moine A, Cobbold SP, et al. Dominant transplantation tolerance. Opinion. Curr Opin Immunol 2003; 15: 499.
4. Graca L, Le Moine A, Lin CY, et al. Donor-specific transplantation tolerance: the paradoxical behavior of CD4+CD25+ T cells. Proc Natl Acad Sci U S A 2004; 101: 10122.
5. Cobbold SP, Castejon R, Adams E, et al. Induction of foxP3+ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants. J Immunol 2004; 172: 6003.
6. Le Moine A, Surquin M, Demoor FX, et al. IL-5 mediates eosinophilic rejection of MHC class II-disparate skin allografts in mice. J Immunol 1999; 163: 3778.
7. Buonocore S, Flamand V, Goldman M, et al. Bone marrow-derived immature dendritic cells prime in vivo alloreactive T cells for interleukin-4-dependent rejection of major histocompatibility complex class II antigen-disparate cardiac allograft. Transplantation 2003; 75: 407.
8. McHugh RS, Shevach EM. Cutting edge: depletion of CD4+CD25+ regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease. J Immunol 2002; 168: 5979.
9. Monaco AP, Wood ML, Gray JG, et al. Studies on heterologous anti-lymphocyte serum in mice. II. Effect on the immune response. J Immunol 1966; 96: 229.
10. Russell PS, Chase CM, Winn HJ, et al. Coronary atherosclerosis in transplanted mouse hearts. I. Time course and immunogenetic and immunopathological considerations. Am J Pathol 1994; 144: 260.
11. Goldman M, Le Moine A, Braun MY, et al. A role for eosinophils in transplant rejection. Trends Immunol 2001; 22: 247.
12. Shevach EM. CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2002; 2: 389.
13. Curiel TJ, Coukos G, Zou L, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004; 10: 942.
14. Shevach EM. Fatal attraction: tumors beckon regulatory T cells. Nat Med 2004; 10: 900.
15. Terabe M, Berzofsky JA. Immunoregulatory T cells in tumor immunity. Curr Opin Immunol 2004; 16: 157.
16. Aseffa A, Gumy A, Launois P, et al. The early IL-4 response to Leishmania major and the resulting Th2 cell maturation steering progressive disease in BALB/c mice are subject to the control of regulatory CD4+CD25+ T cells. J Immunol 2002; 169: 3232.
17. McKee AS, Pearce EJ. CD25+CD4+ cells contribute to Th2 polarization during helminth infection by suppressing Th1 response development. J Immunol 2004; 173: 1224.
18. Xu D, Liu H, Komai-Koma M, et al. CD4+CD25+ regulatory T cells suppress differentiation and functions of Th1 and Th2 cells, Leishmania major infection, and colitis in mice. J Immunol 2003; 170: 394.
19. Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 2004; 5: 266.
20. Hsieh CS, Liang Y, Tyznik AJ, et al. Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors. Immunity 2004; 21: 267.
21. Leibnitz RR, Lipsky PE, Thiele DL. Reactivity of hybridomas derived from T cells activated in vivo during graft-versus-host disease. J Immunol 1994; 153: 4959.
22. Sayegh MH, Wu Z, Hancock WW, et al. Allograft rejection in a new allospecific CD4+ TCR transgenic mouse. Am J Transplant 2003; 3: 381.
23. Hasegawa S, Becker G, Nagano H, et al. Pattern of graft- and host-specific MHC class II expression in long-term murine cardiac allografts: origin of inflammatory and vascular wall cells. Am J Pathol 1998; 153: 69.
24. Rosenberg AS, Singer A. Cellular basis of skin allograft rejection: an in vivo model of immune-mediated tissue destruction. Annu Rev Immunol 1992; 10: 333.
25. Oldenhove G, de Heusch M, Urbain-Vansanten G, et al. CD4+ CD25+ regulatory T cells control T helper cell type 1 responses to foreign antigens induced by mature dendritic cells in vivo. J Exp Med 2003; 198: 259.
26. Suto A, Nakajima H, Kagami SI, et al. Role of CD4(+) CD25(+) regulatory T cells in T helper 2 cell-mediated allergic inflammation in the airways. Am J Respir Crit Care Med 2001; 164: 680.
27. Stassen M, Jonuleit H, Muller C, et al. Differential regulatory capacity of CD25+ T regulatory cells and preactivated CD25+ T regulatory cells on development, functional activation, and proliferation of Th2 cells. J Immunol 2004; 173: 267.
28. Salama AD, Najafian N, Clarkson MR, et al. Regulatory CD25+ T cells in human kidney transplant recipients. J Am Soc Nephrol 2003; 14: 1643.
29. Meloni F, Vitulo P, Bianco AM, et al. Regulatory CD4+CD25+ T cells in the peripheral blood of lung transplant recipients: correlation with transplant outcome. Transplantation 2004; 77: 762.
30. Vincenti F, Kirkman R, Light S, et al. Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group. N Engl J Med 1998;338:161.
31. Sho M, Yamada A, Najafian N, et al. Physiological mechanisms of regulating alloimmunity: cytokines, CTLA-4, CD25+ cells, and the alloreactive T cell clone size. J Immunol 2002; 169: 3744.